Al-Chalabi A - Search Results

1

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.

Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobágyi T, Shaw CE. Al-Sarraj S, et al. Acta Neuropathol. 2011 Dec;122(6):691-702. doi: 10.1007/s00401-011-0911-2. Epub 2011 Nov 19. Acta Neuropathol. 2011. PMID: 22101323

2

Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis.

al-Chalabi A, Powell JF, Leigh PN. al-Chalabi A, et al. Muscle Nerve. 1995 May;18(5):540-5. doi: 10.1002/mus.880180511. Muscle Nerve. 1995. PMID: 7739643 Review.

3

Mutations in all five exons of SOD-1 may cause ALS.

Shaw CE, Enayat ZE, Chioza BA, Al-Chalabi A, Radunovic A, Powell JF, Leigh PN. Shaw CE, et al. Ann Neurol. 1998 Mar;43(3):390-4. doi: 10.1002/ana.410430319. Ann Neurol. 1998. PMID: 9506558

4

Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor.

Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, Matthijs G, Camu W, Marklund SL, Forsgren L, Rouleau G, Laing NG, Hurse PV, Siddique T, Leigh PN, Powell JF. Al-Chalabi A, et al. Hum Mol Genet. 1998 Dec;7(13):2045-50. doi: 10.1093/hmg/7.13.2045. Hum Mol Genet. 1998. PMID: 9817920

5

Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.

Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Leigh PN. Al-Chalabi A, et al. Hum Mol Genet. 1999 Feb;8(2):157-64. doi: 10.1093/hmg/8.2.157. Hum Mol Genet. 1999. PMID: 9931323

6

Progress in the pathogenesis of amyotrophic lateral sclerosis.

Shaw CE, al-Chalabi A, Leigh N. Shaw CE, et al. Curr Neurol Neurosci Rep. 2001 Jan;1(1):69-76. doi: 10.1007/s11910-001-0078-7. Curr Neurol Neurosci Rep. 2001. PMID: 11898502 Review.

7

No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS.

Broom WJ, Parton MJ, Vance CA, Russ C, Andersen PM, Hansen V, Leigh PN, Powell JF, Al-Chalabi A, Shaw CE. Broom WJ, et al. Neurology. 2004 Dec 28;63(12):2419-22. doi: 10.1212/01.wnl.0000147264.60349.eb. Neurology. 2004. PMID: 15623718

8

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, Brooks DJ, Leigh PN. Turner MR, et al. Brain. 2005 Apr;128(Pt 4):896-905. doi: 10.1093/brain/awh428. Epub 2005 Feb 2. Brain. 2005. PMID: 15689356

9

Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?

Al-Chalabi A, Leigh PN. Al-Chalabi A, et al. Brain. 2005 Mar;128(Pt 3):451-3. doi: 10.1093/brain/awh426. Brain. 2005. PMID: 15713848 Review. No abstract available.

10

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, Leigh PN. Turner MR, et al. Brain. 2005 Jun;128(Pt 6):1323-9. doi: 10.1093/brain/awh509. Epub 2005 Apr 20. Brain. 2005. PMID: 15843422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results